White patients were more likely to access a GLP-1 prescription than their Black and Hispanic counterparts, giving credence to fears of race-based health disparities with the blockbuster weight loss drug.
The data, published as a research note…
White patients were more likely to access a GLP-1 prescription than their Black and Hispanic counterparts, giving credence to fears of race-based health disparities with the blockbuster weight loss drug.
The data, published as a research note…